Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 60Head and Neck Neoplasms 22Squamous Cell Carcinoma of Head and Neck 21Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Melanoma 17Colonic Neoplasms 16Rectal Neoplasms 15Carcinoma, Renal Cell 13Pancreatic Neoplasms 12Lymphoma 12Prostatic Neoplasms 11Ovarian Neoplasms 11Lymphoma, Follicular 11Carcinoma, Ovarian Epithelial 11Kidney Neoplasms 9Breast Neoplasms, Male 9Salivary Gland Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Central Nervous System Neoplasms 8Sarcoma 7Liver Neoplasms 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Unspecified Adult Solid Tumor, Protocol Specific 6Neuroblastoma 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

Rituximab 10Valganciclovir 6Etoposide 4Doxorubicin 4Valacyclovir 3Gemcitabine 3Dexamethasone 3Cyclophosphamide 3Cisplatin 3spartalizumab 2pembrolizumab 2pegaspargase 2Zidovudine 2Vincristine 2Radiotherapy, Intensity-Modulated 2Prednisone 2Methylprednisolone 2Methotrexate 2Matrix-M 2Leucovorin 2Lenalidomide 2Cell Count 2Carboplatin 2Blood Specimen Collection 2Acyclovir 2valomaciclovir 1toripalimab 1threonic acid 1ruxolitinib 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Immunohistochemistry × Clear all
NCT01490801 2016-05-17

Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

Children's Oncology Group

Completed
50 enrolled
LymphoidMyeloid

Hodgkin Disease, Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡